| Timothy Allen Treece, MD | |
|
5005 Arlington Centre Blvd, Columbus, OH 43220-2912 | |
| (614) 246-6900 | |
| (614) 246-6909 |
| Full Name | Timothy Allen Treece |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 42 Years |
| Location | 5005 Arlington Centre Blvd, Columbus, Ohio |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518958339 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 35059861 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbus Aesthetic And Plastic Surgery, Inc | 6103865837 | 5 |
News Archive
Scientists at the Dana-Farber/Children's Hospital Cancer Center have developed an anti-cancer peptide that overcomes the stubborn resistance to chemotherapy and radiation often encountered in certain blood cancers when the disease recurs following initial treatment.
Pressure measurements enable a newly developed fall detector to "observe" falls that current sensors do not register, thus improving safety for older people who live at home.
U-Systems, the leader in automated breast ultrasound, announced today it has received a PMA approvable letter from the U.S. Food and Drug Administration's (FDA) for the company's somo•v® Automated Breast Ultrasound (ABUS) system.
A new study published in the July 11 issue of the Journal of Neuroscience details the development of the first mouse model engineered to carry the most common mutation in Usher syndrome III causative gene (Clarin-1) in North America.
› Verified 8 days ago
| Entity Name | Columbus Aesthetic And Plastic Surgery, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699801555 PECOS PAC ID: 6103865837 Enrollment ID: O20050502000689 |
News Archive
Scientists at the Dana-Farber/Children's Hospital Cancer Center have developed an anti-cancer peptide that overcomes the stubborn resistance to chemotherapy and radiation often encountered in certain blood cancers when the disease recurs following initial treatment.
Pressure measurements enable a newly developed fall detector to "observe" falls that current sensors do not register, thus improving safety for older people who live at home.
U-Systems, the leader in automated breast ultrasound, announced today it has received a PMA approvable letter from the U.S. Food and Drug Administration's (FDA) for the company's somo•v® Automated Breast Ultrasound (ABUS) system.
A new study published in the July 11 issue of the Journal of Neuroscience details the development of the first mouse model engineered to carry the most common mutation in Usher syndrome III causative gene (Clarin-1) in North America.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy Allen Treece, MD 5005 Arlington Centre Blvd, Columbus, OH 43220-2912 Ph: (614) 246-6900 | Timothy Allen Treece, MD 5005 Arlington Centre Blvd, Columbus, OH 43220-2912 Ph: (614) 246-6900 |
News Archive
Scientists at the Dana-Farber/Children's Hospital Cancer Center have developed an anti-cancer peptide that overcomes the stubborn resistance to chemotherapy and radiation often encountered in certain blood cancers when the disease recurs following initial treatment.
Pressure measurements enable a newly developed fall detector to "observe" falls that current sensors do not register, thus improving safety for older people who live at home.
U-Systems, the leader in automated breast ultrasound, announced today it has received a PMA approvable letter from the U.S. Food and Drug Administration's (FDA) for the company's somo•v® Automated Breast Ultrasound (ABUS) system.
A new study published in the July 11 issue of the Journal of Neuroscience details the development of the first mouse model engineered to carry the most common mutation in Usher syndrome III causative gene (Clarin-1) in North America.
› Verified 8 days ago
Dr. Aditya Sood, M.D., M.B.A. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 915 Olentangy River Rd Ste 2140, Columbus, OH 43212 Phone: 614-293-8566 Fax: 614-293-3381 | |
Kim A. Bjorklund, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 555 S 18th St, Columbus, OH 43205 Phone: 614-722-6200 | |
Patrick W Harbour, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 915 Olentangy River Rd Ste 2140, Columbus, OH 43212 Phone: 614-293-8566 Fax: 614-293-3381 | |
Dr. Kerry-ann Stewart Mitchell, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 915 Olentangy River Rd, Columbus, OH 43212 Phone: 614-293-8566 Fax: 614-293-3381 | |
Dr. Cristiane M. Ueno, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 915 Olentangy River Rd, Columbus, OH 43212 Phone: 614-293-8566 Fax: 614-293-3381 | |
Dr. Gan Hok Bing, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3600 Olentangy River Rd Ste 480, Columbus, OH 43214 Phone: 614-457-2233 Fax: 614-457-3012 | |
Dexter W Blome, M.D., PH.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 85 Mcnaughten Rd, Suite 260, Columbus, OH 43213 Phone: 614-755-4155 Fax: 614-755-5104 |